Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 541269 | NSE Symbol : CHEMFAB | ISIN : INE783X01023 | Industry : Chemicals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
24-Jan-2025	30-Jan-2025	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve the unaudited financial results for the quarter ended 31st December 2024 and allotment of shares under the ESOP scheme. Outcome of the Board Meeting (As Per BSE Announcement Dated on 30/01/2025)
25-Oct-2024	04-Nov-2024	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2024 inter alia to consider and approve i. Unaudited Financial Results for the quarter ended 30th September 2024. ii. Allotment of shares under ESOP scheme. Outcome of the Board Meeting (As Per BSE Announcement dated on 04.11.2024)
25-Sep-2024	25-Sep-2024	Others	Outcome of the Board Meeting
26-Jul-2024	08-Aug-2024	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve the unaudited financial results for the quarter ended 30th June 2024 and allotment of shares under the ESOP scheme for the employees. Outcome of the Board Meeting (As Per BSE Announcement dated on 08.08.2024)
08-May-2024	22-May-2024	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 inter alia to consider and approve the Audited Financial Results for the Year Ended 31st March 2024 declare dividend subject to the approval of the Shareholders if any and allot equity shares to the employees those who have exercised their options. Outcome of the Board Meeting (As Per BSE Announcement Dated on: 22/05/2024)
25-Jan-2024	08-Feb-2024	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve the unaudited financial results for the Quarter Ended 31st December 2023. The outcome of the Board Meeting Financial Results - 31st December 2023 (As Per BSE Announcement Dated on 08/02/2024)
10-Oct-2023	26-Oct-2023	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2023 inter alia to consider and approve the Unaudited Financial Results for the Quarter Ended 30th September 2023 and allotment of the equity shares of the Company to the employees who have exercised their options. Outcome of the Board Meeting held on 26th October 2023. (As per BSE Announcement Dated on 26/10/2023)
17-Jul-2023	27-Jul-2023	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve i) Un-Audited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2023. ii) Allotment of Equity shares of the Company to the employees of the Company who have exercised their options under the Chemfab Alkalis Employees Stock Option Scheme (CAESOS 2020). The Board approved the following. 1. Financial Results for the Quarter Ended 30th June 2023. 2. Allotment of Shares under the ESOP Scheme. 3. Recommended to the Shareholders for amending the Articles of Association of the Company. (As per BSE Announcement Dated on 27/07/2023) The Board at the meeting held on 27th July 2023 approved the allotment of 13,300 Shares under the ESOP scheme to the employees who have exercised their options. (As Per BSE Announcement Dated on 28.07.2023)
08-May-2023	18-May-2023	Accounts	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2023 inter alia to consider and approve In line with the requirements of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on Thursday 18th May 2023 at 11:00 AM (IST) to consider and approve inter-alia the following businesses: - i) Audited Standalone and Consolidated Financial Statements for the Quarter and Year Ended 31st March 2023. ii) Allotment of Equity shares of the Company to the employees those who have exercised their option under Chemfab Alkalis Employees Stock Option Scheme (CAESOS 2020). iii) Declaration of Dividend subject to the approval of Shareholders if any. Further pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 the trading window for dealing in the shares of the Company has already commenced and the same shall remain closed for a period of 48 hours from the dissemination of results with the Stock Exchanges. The Board of Directors in the meeting held today i.e.18th May 2023, approved the payment of final dividend for the Financial Year 2022-23, subject to the approval of the shareholders in the ensuing Annual General Meeting. Outcome of the Board Meeting Financial Results for the Quarter and Year Ended 31st March 2023 (As Per BSE Announcement Dated on 18.05.2023)
03-Apr-2023	03-Apr-2023	Others	We wish to inform you that in the meeting of the Board of Directors of the Company held today, the Board approved the borrowings of Rs.31.50 Crores from the HDFC Bank. The Board Meeting was convened at shorter notice with the consent of all the Directors, the meeting commenced at 11:30 AM and concluded at 12:30 PM.
14-Jan-2023	07-Feb-2023	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2023 inter alia to consider and approve i) The Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months Ended 31st December 2022. ii) The Allotment of equity shares under Chemfab Alkalis Employees Stock Option Scheme (CAESOS 2020) to those employees who have exercised their option. We wish to inform you that the Board of Directors at the meeting held on 07th February 2023, approved the allotment of 37,000 Equity Shares of Face Value of Rs.10 under the Chemfab Alkalis Employees Stock option scheme ('CAESOS 2020') to the employees those who have exercised their options. (As per BSE Announcement Dated on 08/02/2023)
18-Oct-2022	03-Nov-2022	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on Thursday 03rd November 2022 at 11:00 AM (IST) to consider and approve inter-alia i) The Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September 2022. ii) The allotment of equity shares under Chemfab Alkalis Employees Stock Option Scheme (CAESOS 2020) to those employees who have exercised their option. Further pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 the trading window for dealing in the shares of the Company has already commenced and the same shall remain closed for a Period of 48 hours from the dissemination of results with the Stock Exchanges. In continuation to the notice of the Board Meeting dated 18th October 2022, we wish to inform you that the meeting of the Board of Directors of the Company held today i.e., 03rd November 2022, the Board inter- alia considered and approved the following: - i. Financial Results for the Quarter and Half Year Ended 30th September 2022. The Board considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September 2022 as recommended by the members of the Audit Committee in the meeting held earlier in the day. The Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September 2022 along with the Limited Review Report issued by the Statutory Auditors of the Company are enclosed herewith. ii. Allotment of ESOP shares Allotment of 8,300 equity shares of the Company of Face Value Rs.10/- to the employee under Chemfab Alkalis Employees Stock Option Scheme ('CAESOS 2020'). Financial Results for the Quarter and Half Year Ended 30th September 2022. The Board considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September 2022 as recommended by the members of the Audit Committee in the meeting held earlier in the day. The Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September 2022 along with the Limited Review Report issued by the Statutory Auditors of the Company are enclosed herewith. (As per BSE Announcement Dated on 03/11/2022) We wish to inform you that the Board of Directors at the meeting held on 03rd November 2022, approved the allotment of 8,300 equity shares of the face value of Rs.10 under the Chemfab Alkalis Employees Stock option scheme ('CAESOS 2020') to the employees those who have exercised their options. (As Per BSE Announcement dated on 04.11.2022)
11-Aug-2022	11-Aug-2022	AGM	We wish to inform you that the meeting of the Board of the Directors of the Company held today i.e., 11th August 2022, the Board at its meeting considered and approved the following matters: - i) The Board approved the re-appointment of M/s. Deloitte Haskins & Sells LLP ('DHS') as the Statutory Auditors of the Company for their second term of four consecutive years subject to the approval of the Shareholders of the Company at the forthcoming Annual General Meeting (AGM). ii) The Board approved the Annual Report of the Company for the Financial Year 2021-2022, which also contained the Notice of the 13th Annual General Meeting. The 13th Annual General Meeting of the Company is proposed to be held on 15th September 2022 at 10:00 AM (IST) through Video Conferencing ('V.C')/Other Audio-Visual Means ('OAVM'). The Board Meeting commenced at 11:00 A.M and Concluded at 12.00 P.M.
15-Jul-2022	27-Jul-2022	Quarterly Results	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2022 inter alia to consider and approve i) The Unaudited Standalone and consolidated Financial Results for the Quarter ended 30th June 2022. ii) The allotment of equity shares under Chemfab Alkalis Employees Stock option Scheme(CAESOS 2020) those who are employees exercised their option. Further pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 the trading window for dealing in the shares of the Company has already commenced and the same shall remain closed for a Period of 48 hours from the dissemination of results with the Stock Exchange. The Board at the meeting held today approved the unaudited financial results for the quarter ended 30th June 2022, and allotted shares to the employees under the ESOP scheme. i) Financial Results for the Quarter Ended 30th June 2022. The Board considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2022 as recommended by the members of the Audit Committee in the meeting held earlier in the day. The Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2022 along with the Limited Review Report issued by the Statutory Auditors of the Company are enclosed herewith (As Per BSE Announcement Dated on 27.07.2022) We wish to inform you that the Board of Directors at the meeting held on 27th July 2022, approved the allotment of 200 equity shares of face value of Rs.10 under the Chemfab Alkalis Employees Stock option scheme ('CAESOS 2020') to the employees those who have exercised their options. In terms of Regulation 10(c) of the SEBI (Share Based Employee Benefits) Regulations, 2021 the details of shares allotted as mentioned above are given in the enclosure. Kindly take the above information on record (As Per BSE Announcement dated on 28.07.2022)
16-May-2022	25-May-2022	Accounts	Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 inter alia to consider and approve i) Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March 2022. ii) Allotment of Equity Shares of the Company to the employees of the Company who have exercised their options under Chemfab Alkalis Employees Stock Option Scheme (CAESOS 2020). iii) Declaration of Dividend subject to the approval of the Shareholders if any. Further pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 the trading window for dealing in the shares of the Company has already commenced and the same shall remain closed for a period of 48 hours from the dissemination of results with the Stock Exchanges. Request you to kindly take the same on record as required under the provisions of the above captioned Regulation. Chemfab Alkalis Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2022, inter alia, recommended to the Shareholders for their approval in the ensuing Annual General Meeting a payment of Rs.1.25/- per share as the Final Dividend. In continuation to the Notice of the Board Meeting dated 16th May 2022, we wish to inform you that the meeting of the Board of the Directors of the Company held today i.e., 25th May 2022, the Board inter- alia considered and approved the following: - 1. Audited Standalone and consolidated Financial Results for the Quarter and Year Ended 31st March 2022 as recommended by the members of the Audit Committee in the meeting held earlier in the day. We are also enclosing here with the Financial Results as approved by the Board along with the report of the Statutory Auditors including the declaration on Unmodified Opinion. 2. Allotment of 2,700 Equity Shares of the Company of Face Value Rs. 10/- to the employees those who have exercised their option under 'CAESOS 2020' scheme. 3. Recommended to the Shareholders for their approval in the ensuing Annual General Meeting a payment of Rs.1.25/- per share as the Final Dividend. (As Per BSE Announcement Dated on 25.05.2022) We refer to our letter dated 25th May 2022, wherein we had intimated the outcome of the Board Meeting along with the Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March 2022. We wish to submit that there was an inadvertent error in the 'Earnings Per Equity Share' in the Audited Consolidated Financial Results for the Year Ended 31st March 2022. The correct numbers are reproduced herein below: Consolidated-Earnings Per Equity Share As per communication to the SE on 25th May, 2022 Corrected EPS for the year ended 31st March 2022 Basic 2.53 20.36 Diluted 2.52 20.20 Apart from the above there are no other corrections to the Audited Standalone and consolidated financial statements for the quarter and year ended 31st March 2022, submitted by us on 25th May 2022. (As Per BSE Announcement Dated on 26/05/2022)

1 2

LOGIN HERE

Chemfab Alkalis Ltd

Board Meeting